N@N

Tyler Van Buren Initiated (TVTX) at Buy and Held Target at $30 on, May 22nd, 2023

Tyler Van Buren of TD Cowen, Initiated "Travere Therapeutics, Inc." (TVTX) at Buy and Held Target at $30 on, May 22nd, 2023.

Tyler has made no other calls on TVTX in the last 4 months.

There are 9 other peers that have a rating on TVTX. Out of the 9 peers that are also analyzing TVTX, 0 agree with Tyler's Rating of Hold.

These are the ratings of the 9 analyists that currently disagree with Tyler

---

• Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $22 on, Tuesday, May 2nd, 2023
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $39 on, Tuesday, May 2nd, 2023
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $26 on, Tuesday, May 2nd, 2023
• Mohit Bansal of "Wells Fargo" Maintained at Buy with Decreased Target to $24 on, Tuesday, May 2nd, 2023
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $23 on, Tuesday, May 2nd, 2023
• Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $29 on, Monday, April 17th, 2023
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, February 28th, 2023
• Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $31 on, Tuesday, February 21st, 2023
• Do Kim of "Piper Sandler" Maintained at Buy with Increased Target to $46 on, Tuesday, February 21st, 2023

Contributing Sources

---